{"id":"alkaline-citrate","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset (nausea, diarrhea)"},{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Metabolic alkalosis"}]},"_chembl":{"chemblId":"CHEMBL1200667","moleculeType":"Small molecule","molecularWeight":"598.09"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Alkaline citrate works by increasing urinary alkalinity, which decreases the solubility of uric acid and calcium oxalate crystals, thereby preventing kidney stone formation and promoting dissolution of existing stones. Citrate also acts as a stone inhibitor by binding to calcium and reducing crystal aggregation. This mechanism is particularly effective for uric acid stones and calcium oxalate nephrolithiasis.","oneSentence":"Alkaline citrate raises urinary pH to reduce stone formation and dissolution of existing calculi.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:00:38.675Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of recurrent kidney stones (nephrolithiasis)"},{"name":"Uric acid stone disease"}]},"trialDetails":[{"nctId":"NCT07309640","phase":"NA","title":"The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)","status":"NOT_YET_RECRUITING","sponsor":"Universiti Sains Malaysia","startDate":"2026-01-01","conditions":"Magnesium During Orthodontic Expansion, Orthodontic Patients Indicated for Maxillary Expansion","enrollment":38},{"nctId":"NCT07206524","phase":"NA","title":"Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation","status":"RECRUITING","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2025-06-05","conditions":"Hemodialysis, Thromboinflammation, Hemodialysis Complication","enrollment":15},{"nctId":"NCT06091007","phase":"NA","title":"Magnesium Citrate Supplementation on Hand Grip Strength","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2023-11-17","conditions":"Hand Grasp","enrollment":21},{"nctId":"NCT00580047","phase":"NA","title":"Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2003-12-01","conditions":"Renal Insufficiency","enrollment":59},{"nctId":"NCT05023122","phase":"NA","title":"The Effect of Oral Vitamin D Supplements on Fusion Outcome in Patients Receiving Elective Lumbar Spinal Fusion","status":"COMPLETED","sponsor":"Show Chwan Memorial Hospital","startDate":"2016-01-01","conditions":"Vitamin D, Spinal Fusion, Lumbar Spine Disease","enrollment":34},{"nctId":"NCT01385098","phase":"NA","title":"Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients","status":"COMPLETED","sponsor":"Vadim Sherman, MD","startDate":"2011-07","conditions":"Obesity, Vitamin D Deficiency","enrollment":37},{"nctId":"NCT03396380","phase":"PHASE3","title":"Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2017-07-01","conditions":"Ovulation Induction","enrollment":186},{"nctId":"NCT03353636","phase":"NA","title":"Bioavailability of Magnesium Supplements","status":"COMPLETED","sponsor":"Natural Calm Canada","startDate":"2016-06-27","conditions":"Healthy, Magnesium Deficiency","enrollment":12},{"nctId":"NCT00416715","phase":"PHASE2","title":"Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2006-10","conditions":"Arthralgia, Musculoskeletal Complications, Pain","enrollment":100},{"nctId":"NCT03203096","phase":"NA","title":"Magnesium Supplementation in Stress Conditions","status":"COMPLETED","sponsor":"Protina Pharmazeutische GmbH","startDate":"2017-01-15","conditions":"Stress Physiology","enrollment":70},{"nctId":"NCT00808470","phase":"PHASE2","title":"Micronutrients to Prevent Noise-induced Hearing Loss","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2008-10","conditions":"Noise-Induced Hearing Loss","enrollment":72},{"nctId":"NCT00321932","phase":"PHASE2","title":"Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2005-07","conditions":"Leukemia, Lymphoma, Myelodysplastic Syndromes","enrollment":61},{"nctId":"NCT01022229","phase":"PHASE3","title":"The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2013-11","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":16},{"nctId":"NCT00704990","phase":"PHASE2, PHASE3","title":"Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Kieran Cooley","startDate":"2008-09","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":28},{"nctId":"NCT00249951","phase":"PHASE3","title":"Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2005-11","conditions":"Nephrocalcinosis","enrollment":80},{"nctId":"NCT00737815","phase":"NA","title":"Randomized Crossover Study of Magnesium Supplementation","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2007-06","conditions":"Diabetes Mellitus, Type 2, Inflammation","enrollment":14},{"nctId":"NCT00040235","phase":"PHASE3","title":"Magnesium Effects in Apheresis","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2002-06","conditions":"Healthy","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["no brand names, Shol's solution versus placebo solution (NaCl 0.9 %)"],"phase":"phase_3","status":"active","brandName":"Alkaline citrate","genericName":"Alkaline citrate","companyName":"University of Cologne","companyId":"university-of-cologne","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Alkaline citrate raises urinary pH to reduce stone formation and dissolution of existing calculi. Used for Prevention and treatment of recurrent kidney stones (nephrolithiasis), Uric acid stone disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}